Overton's nomination withdrawal means no clear end for FDA leadership vacuum
Source: The Hill
The White House's abrupt withdrawal of Heidi Overton as President Trump's nominee to lead the Food and Drug Administration (FDA) means the agency will remain without stable leadership six months after the former commissioner resigned, leaving industr
This is aggregated or syndicated coverage. Reporting and media belong to the original publisher.
Read the original source at The Hill